ArticleOncogene2016

Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties.

A N Paranjape et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.